These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22365333)

  • 1. Virus-specific CD8⁺ T-cells detected in PBMC from horses vaccinated against African horse sickness virus.
    Pretorius A; Van Kleef M; Van Wyngaardt W; Heath J
    Vet Immunol Immunopathol; 2012 Mar; 146(1):81-6. PubMed ID: 22365333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses.
    El Garch H; Crafford JE; Amouyal P; Durand PY; Edlund Toulemonde C; Lemaitre L; Cozette V; Guthrie A; Minke JM
    Vet Immunol Immunopathol; 2012 Sep; 149(1-2):76-85. PubMed ID: 22763149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
    Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
    Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune gene expression profiling of PBMC isolated from horses vaccinated with attenuated African horsesickness virus serotype 4.
    Pretorius A; Faber FE; van Kleef M
    Immunobiology; 2016 Feb; 221(2):236-44. PubMed ID: 26382058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6.
    von Teichman BF; Dungu B; Smit TK
    Vaccine; 2010 Sep; 28(39):6505-17. PubMed ID: 20638456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals.
    von Teichman BF; Smit TK
    Vaccine; 2008 Sep; 26(39):5014-21. PubMed ID: 18682269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. African horse sickness in The Gambia: circulation of a live-attenuated vaccine-derived strain.
    Oura CA; Ivens PA; Bachanek-Bankowska K; Bin-Tarif A; Jallow DB; Sailleau C; Maan S; Mertens PC; Batten CA
    Epidemiol Infect; 2012 Mar; 140(3):462-5. PubMed ID: 21733265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological response of foals to polyvalent and monovalent live-attenuated African horse sickness virus vaccines.
    Crafford JE; Lourens CW; Smit TK; Gardner IA; MacLachlan NJ; Guthrie AJ
    Vaccine; 2014 Jun; 32(29):3611-6. PubMed ID: 24814557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of the immunoenzyme test ELISA-NS3 to distinguish horses infected by African horsesickness virus from vaccinated horses].
    Idrissi Bougrine S; Fassi Fihri O; el Harrak M; Fassi Fehri MM
    Rev Sci Tech; 1999 Dec; 18(3):618-26. PubMed ID: 10588005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A flow cytometric assay for the expression of interferon gamma in T lymphocytes and its application in the study of EIAV-induced immune response].
    Lin Y; Deng X; Shen N; Zhao L; Meng Q; Max J; Wang J; Shao Y; Zhou J
    Wei Sheng Wu Xue Bao; 2008 Jun; 48(6):800-5. PubMed ID: 18720846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with VP2 is sufficient for protection against lethal challenge with African horsesickness virus Type 4.
    Stone-Marschat MA; Moss SR; Burrage TG; Barber ML; Roy P; Laegreid WW
    Virology; 1996 Jun; 220(1):219-22. PubMed ID: 8659117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
    Maree S; Paweska JT
    J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive transfer and rate of decay of maternal antibody against African horse sickness virus in South African Thoroughbred foals.
    Crafford JE; Lourens CW; Gardner IA; Maclachlan NJ; Guthrie AJ
    Equine Vet J; 2013 Sep; 45(5):604-7. PubMed ID: 23294121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge.
    Roy P; Bishop DH; Howard S; Aitchison H; Erasmus B
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2053-7. PubMed ID: 8811002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge.
    Calvo-Pinilla E; de la Poza F; Gubbins S; Mertens PP; Ortego J; Castillo-Olivares J
    Antiviral Res; 2015 Apr; 116():27-33. PubMed ID: 25643968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-protective immune responses against African horse sickness virus after vaccination with protein NS1 delivered by avian reovirus muNS microspheres and modified vaccinia virus Ankara.
    Marín-López A; Barreiro-Piñeiro N; Utrilla-Trigo S; Barriales D; Benavente J; Nogales A; Martínez-Costas J; Ortego J; Calvo-Pinilla E
    Vaccine; 2020 Jan; 38(4):882-889. PubMed ID: 31708178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.
    Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH
    Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. African horse sickness in naturally infected, immunised horses.
    Weyer CT; Quan M; Joone C; Lourens CW; MacLachlan NJ; Guthrie AJ
    Equine Vet J; 2013 Jan; 45(1):117-9. PubMed ID: 22612775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. African horse sickness virus serotype 4 antigens, VP1-1, VP2-2, VP4, VP7 and NS3, induce cytotoxic T cell responses in vitro.
    Faber FE; van Kleef M; Tshilwane SI; Pretorius A
    Virus Res; 2016 Jul; 220():12-20. PubMed ID: 27063332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of African horse sickness virus nucleic acid and antibody in horses following immunization with a commercial polyvalent live attenuated vaccine.
    Weyer CT; Grewar JD; Burger P; Joone C; Lourens C; MacLachlan NJ; Guthrie AJ
    Vaccine; 2017 Apr; 35(18):2504-2510. PubMed ID: 28341113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.